Dec 9 (Reuters) - CVS Health (CVS) on Tuesday forecast 2026 profit above Wall Street estimates and this year's projected earnings, signalling steady progress in the health conglomerate's turnaround plan.
CVS stock rose 5% in early trading on Tuesday.
The company in October projected double-digit earnings growth for 2026 after raising its 2025 profit forecast for the third time.
"We are closing out 2025 with meaningful momentum across our businesses and we expect another year of strong earnings growth in 2026," said Chief Financial Officer Brian Newman on Tuesday.
The company forecast 2026 adjusted profit to be in the range of $7.00 to $7.20 per share, compared with analysts' average estimate of $7.16, according to data compiled by LSEG.
It, however, expects total revenue of at least $400 billion next year, below analysts' average estimate of $419.26 billion.
CVS also raised its 2025 adjusted profit forecast to $6.60 to $6.70 per share from $6.55 to $6.65 previously.
(Reporting by Sneha S K in Bengaluru; Editing by Shinjini Ganguli)
LATEST POSTS
- 1
As world leaders enter climate talks, people in poverty have the most at stake - 2New York to require social media platforms to display mental health warnings
- 3How did I get my own unique set of fingerprints?
- 4One of the best meteor showers of the year peaks at the worst possible time this week
- 5Why home maintenance deserves a spot in the annual health and budget plans
- Figure out how to Perceive Warnings while Looking for an Auto Collision Lawyer
- Kremlin: Russian troops conquer Pokrovsk after year of intense combat
- Governors Ball 2026: Lorde, A$AP Rocky and Stray Kids set to headline
- South America's Memorable Destinations: A Movement Guide
- 80 km. on foot: Sharren Haskel’s three-day march in protest of haredi draft bill
- Discovering a sense of harmony: Individual Accounts of Reflection and Care
- BravoCon 2025: How to watch, full schedule and lineup, where to stream free and more
- Happy with Running Shoes for 2024
- 5 Bike Brands for Ordinary Use
